This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
Werte in diesem Artikel
Veeva Systems (NYSE: VEEV) ticks a lot of the boxes that successful growth-seeking investors tend to look for. It boasts a dominant market position, it realizes recurring revenue from sticky subscription services, and it's exposed to the artificial intelligence (AI) megatrend that's reshaping healthcare.For over a decade, Veeva Systems has been building the connective tissue that drugmakers will need to integrate AI into their drug discovery pipelines. Unfortunately for new investors, Veeva's prescient positioning isn't a secret. The stock has been trading at a steep valuation.Let's take a closer look at the biopharmaceutical industry's favorite software vendor to see if its shares are a smart buy at recent prices.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Ausgewählte Hebelprodukte auf Ai
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ai
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool
Nachrichten zu Ai Holdings Corp
Analysen zu Ai Holdings Corp
Keine Analysen gefunden.